Metabolic Abnormalities
8 clinical trials · Condition
◉ Watch Metabolic Abnormalities
| Record | Firm | Date |
|---|---|---|
| A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD) (NCT05088460) | Regeneron Pharmaceuticals | 2022-02-28 |
| The SCAPIS-Snus Study (NCT07573319) | Karolinska Institutet | 2013-01-01 |
Track Metabolic Abnormalities automatically
Every clearance here is in the API, with alerts when new ones post.